Page 111 - ITPS-7-3
P. 111

INNOSC Theranostics and
            Pharmacological Sciences                                             Alpha-2A receptor agonist and addiction



               doi: 10.1016/j.jns.2020.116733                     Ann N Y Acad Sci. 2017;1394(1):31-54.
            85.  Gold MS, Badgaiyan RD, Blum K. A shared molecular and      doi: 10.1111/nyas.12985
               genetic basis for food and drug addiction: Overcoming   95.  Lefaucheur JP, André-Obadia N, Antal A, et al. Evidence-
               hypodopaminergic  trait/state by incorporating dopamine   based guidelines on the therapeutic use of repetitive
               agonistic  therapy  in  psychiatry.  Psychiatr Clin North Am.   transcranial  magnetic  stimulation  (rTMS).  Clin
               2015;38(3):419-462.                                Neurophysiol. 2014;125(11):2150-2206.
               doi: 10.1016/j.psc.2015.05.011                     doi: 10.1016/j.clinph.2014.05.021
            86.  Blum K, Gold MS. Neuro-chemical activation of brain   96.  Diana M, Raij T, Melis M, Nummenmaa A, Leggio L, Bonci A.
               reward meso-limbic circuitry is associated with relapse   Rehabilitating the addicted brain with transcranial magnetic
               prevention and drug hunger: A hypothesis. Med Hypotheses.   stimulation. Nat Rev Neurosci. 2017;18(11):685-693.
               2011;76(4):576-584.
                                                                  doi: 10.1038/nrn.2017.113
               doi: 10.1016/j.mehy.2011.01.005
                                                               97.  Ekhtiari H, Tavakoli H, Addolorato G,  et  al. Transcranial
            87.  Blum K, Liu Y, Shriner R, Gold MS. Reward circuitry   electrical and magnetic stimulation (tES and TMS) for
               dopaminergic activation regulates food and drug craving   addiction medicine: A consensus paper on the present state
               behavior. Curr Pharm Des. 2011;17(12):1158-1167.   of the science and the road ahead. Neurosci Biobehav Rev.
               doi: 10.2174/138161211795656819                    2019;104:118-140.
            88.  Blum K, Oscar-Berman M, Blum SH,  et al. Can genetic      doi: 10.1016/j.neubiorev.2019.06.007
               testing coupled with enhanced dopaminergic activation   98.  Zhang JJQ, Fong KNK, Ouyang RG, Siu AMH, Kranz GS.
               reduce recidivism rates in the workers compensation legacy   Effects of repetitive transcranial magnetic stimulation
               cases? J Alcohol Drug Depend. 2014;2(3):161.       (rTMS) on craving and substance consumption in patients
               doi: 10.4172/2329-6488.1000161                     with substance dependence: A systematic review and meta-
                                                                  analysis. Addiction. 2019;114(12):2137-2149.
            89.  Blum K, Oscar-Berman M, Demetrovics Z, Barh D, Gold  MS.
               Genetic addiction risk score (GARS): Molecular neurogenetic      doi: 10.1111/add.14753
               evidence for predisposition to Reward Deficiency Syndrome   99.  Coles AS, Kozak K, George TP. A review of brain stimulation
               (RDS). Mol Neurobiol. 2014;50(3):765-796.          methods to treat substance use disorders.  Am  J Addict.
                                                                  2018;27(2):71-91.
               doi: 10.1007/s12035-014-8726-5
                                                                  doi: 10.1111/ajad.12674
            90.  Blum  K,  Oscar-Berman  M,  Jacobs  W,  McLaughlin  T,
               Gold MS. buprenorphine response as a function of   100. Salling MC, Martinez D. Brain stimulation in addiction.
               neurogenetic polymorphic antecedents: Can  dopamine   Neuropsychopharmacology. 2016;41(12):2798-2809.
               genes affect clinical outcomes in reward deficiency syndrome      doi: 10.1038/npp.2016.80.
               (RDS)? J Addict Res Ther. 2014;5:1000185.
                                                               101. Song  S, Zilverstand A,  Gui W,  Li HJ,  Zhou X.  Effects  of
               doi: 10.4172/2155-6105.1000185                     single session versus multi-session non-invasive brain
            91.  Sibai M, Mishlen K, Nunes EV, Levin FR, Mariani   JJ,   stimulation on craving and consumption in individuals with
               Bisaga   A. A  week-long outpatient induction onto   drug addiction, eating disorders or obesity: A meta-analysis.
               XR-naltrexone in patients  with opioid use disorder.  Am J   Brain Stimul. 2019;12(3):606-618.
               Drug Alcohol Abuse. 2020;46(3):289-296.            doi: 10.1016/j.brs.2018.12.975
               doi: 10.1080/00952990.2019.1700265              102. Robison LS, Alessi L, Thanos PK. Chronic forced exercise
            92.  Gowing L, Ali R, White JM, Mbewe D. Buprenorphine for   inhibits stress-induced reinstatement of cocaine conditioned
               managing opioid withdrawal. Cochrane Database Syst Rev.   place preference. Behav Brain Res. 2018;353:176-184.
               2017;2(2):CD002025.                                doi: 10.1016/j.bbr.2018.07.009
               doi: 10.1002/14651858.CD002025.pub5             103. Swenson S, Blum K, McLaughlin T, Gold MS, Thanos PK.
            93.  Makani R, Pradhan B, Shah U, Parikh T. Role of repetitive   The therapeutic potential of exercise for neuropsychiatric
               transcranial magnetic stimulation (rTMS) in treatment of   diseases: A review. J Neurol Sci. 2020;412:116763.
               addiction and related disorders: a systematic review. Curr      doi: 10.1016/j.jns.2020.116763
               Drug Abuse Rev. 2017;10(1):31-43.
                                                               104. Swenson S, Hamilton J, Robison L, Thanos PK. Chronic
               doi: 10.2174/1874473710666171129225914             aerobic exercise: Lack of effect on brain CB1 receptor levels
                                                                  in adult rats. Life Sci. 2019;230:84-88.
            94.  Dunlop K, Hanlon CA, Downar J. Noninvasive brain
               stimulation treatments for addiction and major depression.      doi: 10.1016/j.lfs.2019.05.058


            Volume 7 Issue 3 (2024)                         17                               doi: 10.36922/itps.1918
   106   107   108   109   110   111   112   113   114   115   116